Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

Grades 2–3 and Pain Numeric Rating Scale (NRS [0–10]) scores between 4 and 8 in the target knee. Cumulative frequency ...

Organogenesis (ORGO) announced the favorable outcome of the interim analysis of its second Phase 3 randomized control trial of ReNu, a ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and ...

Long acting injection Fluticasone promising in knee osteoarthritis suggests a new study published in the The Lancet ...

This treatment uses the body’s natural healing processes to potentially improve joint health and mobility, making it an ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for the treatment of osteoarthritis of the knee. GNSC-001 is an investigational, adeno-associated virus gene ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As ...